Prognostic factors for recurrence in patients with colon cancer
Keywords:
Neoplasias del Colon /colorrectal, factores pronósticos, recurrencia.Abstract
Introduction: Adequate stratification of patients with colon cancer to identify the risk of disease recurrence continues be a challenge.
Objective: To identify prognostic factors associated with colon cancer recurrence.
Methods: A case-control study was carried out, including 63 patients with colon cancer recurrence (cases) and 63 without (controls), treated in three hospitals of Santiago de Cuba province. Binary logistic regression was used to identify prognostic factors.
Results: Poor prognostic factors were lymph node ratio greater than or equal to 0.25, N2 category and lymphovascular invasion, and TNM stage I-II as a good prognostic factor.
Conclusions: The presence of pathological nodal infiltration, lymph node ratio and lymphovascular invasion were associated with a higher recurrence of the disease, so they should be taken into account to predict this event.
Downloads
References
1.Aguado López H. Efecto de la localización del tumor primario y del estadio tumoral sobre el patrón de recurrencia y la supervivencia en el cáncer de colon. [Tesis]. Alcalá de Henares-España: Universidad de Alcalá;2023 [citado 25/11/2023]. 309 p. Disponible en: https://ebuah.uah.es/dspace/bitstream/handle/10017/58074/Tesis%20Hector%20Aguado%20Lopez.pdf?sequence=1&isAllowed=y
2.Sahakyan AM, Aleksanyan A, Batikyan H, Petrosyan H, Yesayan S. Recurrence After Colectomy for Locally Advanced Colon Cancer: Experience from a Developing Country. Indian journal of surgical oncology, 2023 [citado 25/11/2023];14(2):339–44. Disponible en: https://link.springer.com/article/10.1007/s13193-022-01672-x
3.Tao Zhang T, Miao YC. Evaluación pronóstica del índice inmunoinflamatorio sistémico preoperatorio en pacientes con cáncer colorrectal. Frente Oncol. 2023 [citado 05/03/2023]; 13. Disponible en: https://www.frontiersin.org/articles/10.3389/fonc.2023.1260796/full
4.Viñal D, Martínez Recio S, Martínez Pérez D, Ruiz Gutiérrez I, Jiménez Bou D, Peña López J et al. Puntuación clínica para predecir la recurrencia en pacientes con cáncer de colon en estadio II y estadio III. Cánceres 2022[citado 08/03/2023]; 14 (23): 5891.Disponible en: https://www.mdpi.com/2072-6694/14/23/58917
5.Ligorred Padilla LA. Análisis de la influencia de factores clínicos e histopatológicos sobre la supervivencia específica del cáncer en los pacientes intervenidos de adenocarcinoma de colon en estadio II con evolución a estadio IV .[Tesis]. Zaragoza: Universidad de Zaragoza; 2016 [citado 28/03/2023]. 232 p. Disponible en: https://zaguan.unizar.es/record/47418/files/TESIS-2016-026.pdf
6.Canal Boyero MJ. Análisis de la supervivencia por cáncer de colon en la provincia de Salamanca durante el periodo 2005-2011 [Tesisl]. Salamanca: Universidad de Salamanca; 2022[citado 13/03/2023]. 168 p. Disponible en: https://gredos.usal.es/bitstream/handle/10366/150073/PDB_CanalBoyeroMJ_Supervivencia.pdf?sequence=1&isAllowed=y
7.Hernández García A . Análisis de los factores pronósticos en el cáncer de colon estadio II y III [Tesis]. Zaragoza: Universidad de Zaragoza;2019[citado 18/02/2023] 369 p. Disponible en: https://zaguan.unizar.es/record/79653/files/TESIS-2019-130.pdf
8. Cheng DX, Xu KD, Liu HB, Liu Y. Prognostic value of a nomogram model for postoperative liver metastasis of colon cancer. World J Gastrointest Surg. 2024. [citado 31/11/2023];16(4):1055-1065. Disponible en: https://pmc-ncbi-nlm-nihgov.translate.goog/articles/PMC11056678/?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc
9.Jung HS, Ryoo SB, Lim HK, Kim MJ, Moon SH, Park JW, et al. Tumor Size >5 cm and Harvested LNs <12 Are the Risk Factors for Recurrence in Stage I Colon and Rectal Cancer after Radical Resection. Cancers. 2021[citado 23/02/2023];3(21):5294. Disponible en: https://www.mdpi.com/2072-6694/13/21/5294
10.Chen PC, Yeh YM, Lin BW, Chan RH, Su PF, Liu YC et al. Un modelo de predicción de la recurrencia de tumores en pacientes con cáncer colorrectal en estadio II-III: de un modelo de aprendizaje automático al perfil genómico. Biomedicinas.2022[citado 05/03/2023];10(2):340 p. Disponible en: https://www.mdpi.com/2227-9059/10/2/340
11.Manzano Moso JL. Caracterización epigenética de la heterogeneidad intratumoral espacial y temporal. Comparativa entre tumor primario y metástasis hepáticas de cáncer colorrectal [Tesis].Barcelona: Universidad Autónoma de Barcelona; 2022[citado 28/03/2023].Disponible en: https://www.tdx.cat/bitstream/handle/10803/675863/jlmm1de1.pdf?sequence=1
12.Takenaka Y, Miyoshi N, Fujino S, Takahashi Y, Nishimura J, Yasui M, et al. Desarrollo de un nuevo modelo de predicción para el cáncer de colon recurrente en estadio II. Cirugía Hoy.2020[citado 23/02/2023]; 50: 389-95.Disponible en: https://link.springer.com/article/10.1007/s00595-019-01897-4
13Bingham G, Shetye A, Suresh R, Mirnezami R. Impact of primary tumour location on colorectal liver metastases: A systematic review. World J Clin Oncol. 2020[citado 18/06/2023];11(5).Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC7360521/pdf/WJCO-11-294.pdf
14. Roshandel G, Ghasemi Kebria F, Malekzadeh R. Colorectal Cancer: Epidemiology, Risk Factors, and Prevention. Cancers.2024 [citado 23/02/2023];16(8): 1530.Disponible en: https://www-mdpi-com.translate.goog/2072-6694/16/8/1530?_x_tr_sl=en&_x_tr_tl=es&_x_tr_hl=es&_x_tr_pto=tc
15.Wiesmueller F, Schuetz R, Langheinrich M. Defining early recurrence in patients with resected primary colorectal carcinoma and its respective risk factors. Int J Colorectal Dis .2021 [citado 05/03/2023]; 36:1181-91. Disponible en: https://link.springer.com/article/10.1007/s00384-021-03844-7
16.Carvajal CA, Galvis Rocancio D, Reyes Cortes OI. Lateralidad del cáncer de colon y diferencias pronósticas un escenario de vida real en una institución oncológica [Tesis]. Bogotá- Colombia: Universidad del Rosario; 2021[citado 05/12/2023]. 38 p. Disponible en: https://repository.urosario.edu.co/server/api/core/bitstreams/368111a9-98c9-48db-a0b3-dfda975f9818/content
17.Boute TC, Swartjes H, Greuter MJE, Elferink MAG, Eekelen R, Vink GR. Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study. Cancer research communications. 2024 [citado 03/04/2024];4(2):607–616.Disponible en: https://aacrjournals.org/cancerrescommun/article/4/2/607/734970/Cumulative-Incidence-Risk-Factors-and-Overall
18.Fortea C, Martinez D, Escrig J. The lymph node status as a prognostic factor in colon cancer: Comparative population study of classifications using the logarithm of the ratio between metastatic and nonmetastatic nodes (LODDS) versus the pN-TNM classification and ganglion ratio systems. BMC Cancer. 2018[citado 09/12/2023];(18): 1208.Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6280498/pdf/12885_2018_Article_5048.pdf
19.Ulanja MB, Rishi M, Beutler BD, Sharma M, Patterson DR et al. Colon Cancer Sidedness, Presentation, and Survival at Different Stages. Journal of Oncology. 2019 [citado 18/06/2023]. Disponible en: https://pmc.ncbi.nlm.nih.gov/articles/PMC6409047/pdf/JO2019-4315032.pdf
20.Bianchi G, Annicchiarico A, Morini A, Pagliai L, Crafa P, Leonardi F et al. Tres resultados distintos en pacientes con adenocarcinoma colorrectal e invasión linfovascular: lo bueno, lo malo y lo feo. Revista internacional de enfermedades colorrectales. 2021[citado 09/12/2023];36(12):2671-81. Disponible en: https://link.springer.com/article/10.1007/s00384-021-04004-7
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 MEDISAN
This work is licensed under a Creative Commons Attribution 4.0 International License.
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
